Last reviewed · How we verify

NCT03263390

Modeling the Neurological Basis and Characterizing the Neurological Phenotype of Obesity Using Human Neural Stem Cells

Terminated Last updated 16 December 2020
What this trial tests

trial testing Bariatric Surgery in Obesity, Morbid in 6 participants. Terminated before completion.

Timeline
5 October 2017
Primary endpoint
10 August 2020
10 August 2020

Quick facts

Lead sponsorUniversity of California, San Diego
StatusTerminated
Study typeOBSERVATIONAL
Enrollment6
Start date5 October 2017
Primary completion10 August 2020
Estimated completion10 August 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Diego

Who can join

Adults 18 to 90, any sex, with Obesity, Morbid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to characterize the neurological basis of obesity and response to surgical and medical treatment by inducing adult pluripotent stem cells into neuronal cells from subjects that have demonstrated extreme response to bariatric surgery or pharmacological treatment for obesity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Bariatric Surgery

Trials testing the same drug.

Other recruiting trials for Obesity, Morbid

Currently open trials in the same condition.

Other University of California, San Diego trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03263390.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing